1,725 results match your criteria: "Cystic Diseases of the Kidney"
Am J Physiol Renal Physiol
December 2024
Section of Cardio-Renal Physiology and Medicine, Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States.
Most patients with autosomal dominant polycystic kidney disease (ADPKD) develop kidney cysts due to germline mutations. In the kidney, loss impairs epithelial cell integrity and increases macrophage infiltration, contributing to cyst growth. Despite its role as the body's largest inflammatory cell reservoir, it has yet to be elucidated whether a similar phenotype presents in the intestines.
View Article and Find Full Text PDFVirchows Arch
December 2024
Department of Pathology and Laboratory Medicine, Albany Medical Center, 43 New Scotland Avenue, Room F110G3, Albany, NY, USA.
Cysticercosis, although reported in several parts of the body, especially the liver, lesions occurring in the kidney are particularly rare. We report a 58-year-old female patient with intermittent epigastric pain, who was found to have a huge occupancy of the right kidney on computed tomography (CT) and magnetic resonance imaging (MRI), which was confirmed to have a predominantly cystic component, with no clear enhancement on CT images after injection of contrast medium, and significant enhancement of the peritoneum and septum visible on MRI. This case reports a case and its rarity of cysticercosis occurring in the kidney.
View Article and Find Full Text PDFExp Cell Res
January 2025
Department of Cell Biology and Physiology and the Kidney Institute, University of Kansas Medical Center, Kansas City, KS, USA. Electronic address:
Int J Surg Pathol
November 2024
Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Mucinous borderline tumors of the pelvicalyceal system are exceedingly rare tumors with very little information regarding their clinicopathological characteristics and molecular underpinnings in the published literature. Herein, we report two mucinous borderline tumors and review the literature pertaining to these tumors. The patients were women who presented with flank pain without any history of nephrolithiasis.
View Article and Find Full Text PDFOrphanet J Rare Dis
November 2024
Children's Hospital, Pediatrics II, Pediatric Nephrology, University of Duisburg-Essen, Essen, Germany.
Int J Surg Case Rep
December 2024
Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand; Department of Biomedical Science, Faculty of Medicine, Universitas Surabaya, Indonesia.
Ann Pharmacother
September 2024
Department of Pharmacy, Clinical and Administrative Sciences, College of Pharmacy, The University of Oklahoma, Oklahoma City, OK, USA.
Virchows Arch
September 2024
Department of Pathology and Laboratory Medicine, Albany Medical Center, 43 New Scotland Avenue, Room F110G3, Albany, NY, USA.
J Kidney Cancer VHL
August 2024
Division of Urologic Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH.
Adenoid cystic carcinoma (ACC) is a rare tumor, accounting for 1% of all head and neck cancers, with an aggressive nature characterized by local recurrence, delayed metastasis, and survival of less than 50% at 10 years. This is a case of biopsy-proven ACC to the kidney, 1 of 29 known occurrences, managed by metastasectomy by robotic-assisted nephrectomy, with plans for resection of lung metastasis. Thirteen years after diagnosis of sinonasal ACC treated with resection, the patient presented with shortness of breath.
View Article and Find Full Text PDFAnn Transplant
August 2024
Department of Urology, Foch Hospital, Suresnes, France.
J Am Soc Nephrol
December 2024
Université Claude Bernard Lyon 1, INSERM, UMR_S1213, NUDICE, Villeurbanne, France.
Clin Ter
August 2024
Institute of Legal Medicine, Department of Medical and Surgical Sciences, "Magna Graecia" University of Catanzaro, Catanzaro, Italy.
Background: Polycystic kidney disease is a cystic genetic disease. There are two forms: an autosomal dominant one, more common and typical of adults, and an autosomal recessive one, rarer and present in childhood. The autosomal dominant form is caused by genetic mutations of the PKD1 gene in 85% of cases and of PKD2 in 10-15% of cases.
View Article and Find Full Text PDFAutops Case Rep
June 2024
Mount Sinai Medical Center, Arkadi M. Rywlin M.D. Department of Pathology and Laboratory Medicine, Miami Beach, FL, USA.
Autops Case Rep
June 2024
All India Institute of Medical Sciences, Department of Forensic Medicine and Toxicology, Patna, Bihar, India.
Int J Mol Sci
July 2024
Pathology Unit, Vanvitelli University Hospital, 80138 Naples, Italy.
Eur J Hum Genet
September 2024
Department of Human Genetics, McGill University, Montreal, Canada.
Function (Oxf)
September 2024
Departamento de Neurociencia Cognitiva, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Ciudad de México 04510, Mexico.
Sci Rep
July 2024
Division of Nephrology, Department of Medicine, Section of Cardio-Renal Physiology and Medicine, McCallum Basic Health Science Building, University of Alabama at Birmingham, Room 533, 1918 University Blvd, Birmingham, AL, 35233, USA.
Rapamycin slows cystogenesis in murine models of polycystic kidney disease (PKD) but failed in clinical trials, potentially due to insufficient drug dosing. To improve drug efficiency without increasing dose, kidney-specific drug delivery may be used. Mesoscale nanoparticles (MNP) selectively target the proximal tubules in rodents.
View Article and Find Full Text PDFAbdom Radiol (NY)
November 2024
Department of Radiology, University of Washington, Seattle, Washington, 98195, USA.
Contrast-enhanced ultrasound (CEUS) is an advanced ultrasound (US) technique utilizing ultrasound contrast agents (UCAs) to provide detailed visualization of anatomic and vascular architecture, including the depiction of microcirculation. CEUS has been well-established in echocardiography and imaging of focal hepatic lesions and recent studies have also shown the utility of CEUS in non-hepatic applications like the urinary system. The updated guidelines by the European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) from 2018 describe the use of CEUS for non-hepatic applications.
View Article and Find Full Text PDFJpn J Radiol
October 2024
Department of Diagnostic Radiology and Nuclear Medicine, Gunma University Graduate School of Medicine, 3-39-22 Showa, Maebashi, Gunma, 371-8511, Japan.
Minerva Urol Nephrol
August 2024
Department of Urology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, Zhejiang, China -
Int J Mol Sci
April 2024
Research Services, New Mexico Veterans Health Care System, Albuquerque, NM 87108, USA.